2609.3 - Deformation influences arterial distribution: embozene vs embosphere in sheep kidney and uterus (ID: 45180)

V. Verret, J. Pelage, M. Wassef, S. H. Ghegediban, J. Golzarian, A. Laurent

Topic:

Experimental work in IR

Session:

FP 2609 - Embolotherapy: UFE (6 presentations)

2609.2 - Degradation and inflammation of embolization microspheres: embozene vs embosphere in a UAE sheep model (ID: 45177)

V. Verret, M. Wassef, J. Pelage, S. H. Ghegediban, I. Schwartz-Cornil, J. Golzarian, A. Laurent

Topic:

Gynaecological intervention (incl. UFE)

Session:

FP 2609 - Embolotherapy: UFE (6 presentations)

P-163 - DNA-microarray to profile the inflammation on embolization microspheres: comparison of two materials at 1 and 4 weeks in a sheep UAE model (ID: 45179)

V. Verret, I. Schwartz-Cornil, J. Pelage, L. Jouneau, S. H. Ghegediban, M. Wassef, J. Golzarian, A. Laurent

Topic:

Experimental work in IR

Session:

EPOS 2010 - electronic posters (446 presentations)

1701.2 - HepaSphere Microspheres: pre-clinical comparative data for smaller size HepaSphere Microspheres (ID: 133)

V. Verret

Session:

SY 1701 - Merit Medical: HepaSphere Microspheres for HCC: patient outcomes and considerations in embolic sizing (2 presentations)

P-187 - Mechanisms of doxorubicin toxicity on liver after TACE with doxorubicin-loaded microspheres in pigs (ID: 56976)

V. Verret, M. Wassef, S. H. Ghegediban, J. Pelage, J. Namur, M. Bonneau, A. Laurent

Topic:

Experimental work in IR

Session:

EP 2011 - Electronic Posters 2011 (478 presentations)

1306.6 - The size of drug-loaded microspheres influences the local drug delivery and toxicity (ID: 57118)

J. Namur, S. H. Ghegediban, J. Pelage, V. Verret, M. Manfait, M. Wassef, A. Laurent

Topic:

Oncologic intervention

Session:

FP 1306 - Oncologic IR 1 (6 presentations)